38. Vowles KE, Witkiewitz K, Sowden G, Ashworth J. Acceptance and commitment therapy for chronic pain: evidence of mediation and clinically significant change following an abbreviated interdisciplinary program of rehabilitation. J Pain. 2014;15(1):101-113. 39. Anheyer D, Haller H, Barth J, Lauche R, Dobos G, Cramer H. Mindfulness-Based Stress Reduction for Treating Low Back Pain: A Systematic Review and Meta-analysis. Ann Intern Med. 2017;166(11):799-807. 40. Pradhan EK, Baumgarten M, Langenberg P, et al. Effect of Mindfulness-Based Stress Reduction in rheumatoid arthritis patients. Arthritis Rheum. 2007;57(7):1134-1142. 41. Carlson LE, Garland SN. Impact of mindfulness- based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients. Int J Behav Med. 2005;12(4):278- 285. 42. Grossman P, Niemann L, Schmidt S, Walach H. Mindfulness-based stress reduction and health benefits. A meta-analysis. J Psychosom Res. 2004;57(1):35-43. 43. Omidi A, Zargar F. Effects of mindfulness-based stress reduction on perceived stress and psychological health in patients with tension headache. J Res Med Sci. 2015;20(11):1058- 1063. 44. Burger AJ, Lumley MA, Carty JN, et al. The effects of a novel psychological attribution and emotional awareness and expression therapy for chronic musculoskeletal pain: A preliminary, uncontrolled trial. J Psychosom Res. 2016;81:1- 8. 45. Nestoriuc Y, Martin A, Rief W, Andrasik F. Biofeedback treatment for headache disorders: a comprehensive efficacy review. Appl Psychophysiol Biofeedback. 2008;33(3):125- 140. 46. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report. 2008(12):1-23. 47. Kukimoto Y, Ooe N, Ideguchi N. The Effects of Massage Therapy on Pain and Anxiety after Surgery: A Systematic Review and Meta-Analysis. Pain Manag Nurs. 2017;18(6):378-390. 48. Lin YC, Wan L, Jamison RN. Using Integrative Medicine in Pain Management: An Evaluation of Current Evidence. Anesth Analg. 2017;125(6):2081-2093. 49. Millstine D, Chen CY, Bauer B. Complementary and integrative medicine in the management of headache. BMJ. 2017;357:j1805. 50. Wong JJ, Shearer HM, Mior S, et al. Are manual therapies, passive physical modalities, or acupuncture effective for the management of patients with whiplash-associated disorders or neck pain and associated disorders? An update of the Bone and Joint Decade Task Force on Neck Pain and Its Associated Disorders by the OPTIMa collaboration. Spine J. 2016;16(12):1598-1630. 51. Gu Q, Hou JC, Fang XM. Mindfulness Meditation for Primary Headache Pain: A Meta-Analysis. Chin Med J (Engl). 2018;131(7):829-838.
52. Chang DG, Holt JA, Sklar M, Groessl EJ. Yoga as a treatment for chronic low back pain: A systematic review of the literature. J Orthop Rheumatol. 2016;3(1):1-8. 53. Cramer H, Lauche R, Haller H, Dobos G. A systematic review and meta-analysis of yoga for low back pain. Clin J Pain. 2013;29(5):450-460. 54. Groessl EJ, Liu L, Chang DG, et al. Yoga for Military Veterans with Chronic Low Back Pain: A Randomized Clinical Trial. Am J Prev Med. 2017;53(5):599-608. 55. Saper RB, Lemaster C, Delitto A, et al. Yoga, Physical Therapy, or Education for Chronic Low Back Pain: A Randomized Noninferiority Trial. Ann Intern Med. 2017;167(2):85-94. 56. Cramer H, Ward L, Saper R, Fishbein D, Dobos G, Lauche R. The Safety of Yoga: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Epidemiol. 2015;182(4):281-293. 57. Kong LJ, Lauche R, Klose P, et al. Tai Chi for Chronic Pain Conditions: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Sci Rep. 2016;6:25325. 58. Lee MS, Pittler MH, Ernst E. Tai chi for osteoarthritis: a systematic review. Clin Rheumatol. 2008;27(2):211-218. 59. Siddall PJ, Lovell M, MacLeod R. Spirituality: what is its role in pain medicine? Pain Med. 2015;16(1):51-60. 60. U.S. Food and Drug Administration. FDA drug safety communication: prescription acetaminophen products to be limited to 325 mg per dosage unit; boxed warning will highlight potential for severe liver failure. https://www. fda.gov/Drugs/DrugSafety/ucm239821.htm. Published January 13, 2011. Accessed 3-6-18. 61. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain--United States, 2016. JAMA. 2016;315(15):1624-1645. 62. Evoy KE, Morrison MD, Saklad SR. Abuse and Misuse of Pregabalin and Gabapentin. Drugs. 2017;77(4):403-426. 63. National Academies of Sciences Engineering and Medicine. The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. Washington, DC: The National Academies Press; 2017. 64. Kansagara D, O’Neil M, Nugent S, et al. VA Evidence-based Synthesis Program Reports. In: Benefits and Harms of Cannabis in Chronic Pain or Post-traumatic Stress Disorder: A Systematic Review. Washington (DC): Department of Veterans Affairs (US); 2017. 65. U.S. Food and Drug Administration. FDA Approves First Drug Comprised of an Active Ingredient Derived from Marijuana to Treat Rare, Severe Forms of Epilepsy [FDA News Release]. https://www.fda.gov/news-events/ press-announcements/fda-approves-first-drug- comprised-active-ingredient-derived-marijuana- treat-rare-severe-forms Published June 25, 2018. Accessed May 3, 2021. 66. George J. Chronic Pain Patients Find Relief With Cannabis, Despite Varying Evidence. MedPage Today; April 30, 2021.
67. U.S. Food and Drug Administration. FDA Briefing Document: Joint Meeting of the Drug Safety and Risk Management (DSaRM) Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC): Extended-release and Long-acting (ER/LA) Opioid Analgesics Risk Evaluation and Mitigation Strategy (REMS). https://www.fda.gov/AdvisoryCommittees/ Calendar/ucm490628.htm. Published May 3-4, 2016. Accessed 3-7-18. 68. U.S. Food and Drug Administration. Extended- release (ER) and long-acting (LA) opioid analgesics risk evaluation and mitigation strategy (REMS). https://www.fda.gov/downloads/Drugs/ DrugSafety/.../UCM311290.pdf. Published June 2015. Accessed 11-28-18. 69. U.S. Food and Drug Administration. FDA announces enhanced warnings for immediate- release opioid pain medications related to risks of misuse, abuse, addiction, overdose and death. https://www.fda.gov/news-events/ press-announcements/fda-announces- enhanced-warnings-immediate-release-opioid- pain-medications-related-risks-misuse-abuse Published March 22, 2016. Accessed April 27, 2021. 70. U.S. Food and Drug Administration. FDA requires strong warnings for opioid analgesics, prescription opioid cough products, and benzodiazepine labeling related to serious risks and death from combined use. https://www.fda. gov/news-events/press-announcements/fda- requires-strong-warnings-opioid-analgesics- prescription-opioid-cough-products-and- benzodiazepine. Published August 31, 2016. Accessed August 17, 2021. 71. U.S. Food and Drug Administration. Statement by Douglas Throckmorton, M.D., Deputy Center Director for Regulatory Programs in FDA’s Center for Drug Evaluation and Research, on new opioid analgesic labeling changes to give providers better information for how to properly taper patients who are physically dependent on opioids. https://www.fda.gov/news-events/ press-announcements/statement-douglas- throckmorton-md-deputy-center-director- regulatory-programs-fdas-center-drug-0 Published April 9, 2019. Accessed May 3, 2021. 72. U.S. Department of Health and Human Services. HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long- Term Opioid Analgesics. September 2019. 73. Smith HS. Opioid metabolism. Mayo Clin Proc. 2009;84(7):613-624. 74. Overholser BR, Foster DR. Opioid pharmacokinetic drug-drug interactions. Am J Manag Care. 2011;17 Suppl 11:S276-287. 75. U.S. Food and Drug Administration. Use of Codeine and Tramadol Products in Breastfeeding Women - Questions and Answers. https://www. fda.gov/Drugs/DrugSafety/ucm118113.htm. Published April 2017. Accessed 4-10-18. 76. Rolfs RT, Johnson E, Williams NJ, Sundwall DN. Utah clinical guidelines on prescribing opioids for treatment of pain. J Pain Palliat Care Pharmacother. 2010;24(3):219-235.
68
Powered by FlippingBook